Trial Profile
A Phase I bioavailability trial of TW001 oral formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Edaravone (Primary) ; Edaravone
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics